Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The p21 protein-activated kinase 2 pseudogene (ENSG00000237161) is a genomic DNA segment that resembles the functional PAK2 gene but does not produce a functional protein[4]. Pseudogenes arise via gene duplication or retrotransposition and typically contain mutations or truncations that prevent normal expression[2][4]. While the active PAK2 gene encodes a serine/threonine kinase involved in cytoskeleton regulation, cell cycle, apoptosis, and cancer, the pseudogene lacks these functions[3][5]. There is no evidence for biological function or involvement in disease, and it is not considered a valid target for drug development. If you require information on the functional version (PAK2), that would include kinase activity, roles in cell signaling, disease associations, and potential as a therapeutic target[3][1][5]. However, for the pseudogene ENSG00000237161, those details are not applicable.
None applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on p21 protein-activated kinase 2 pseudogene.